Overexpression of USF Increases TGF-β1 Protein Levels, But G1 Phase Arrest was not Induced in FRTL-5 Cells

被引:7
作者
Kim, Keun-Sook [2 ]
Jung, Hye Seung [1 ]
Chung, Yun Jae
Jung, Tae Sik [1 ]
Jang, Hye Won [1 ]
Lee, Myung-Shik [1 ]
Kim, Kwang-Won [1 ]
Chung, Jae Hoon [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Endocrinol & Metab, Seoul 135710, South Korea
[2] Samsung Biomed Res Inst, Seoul, South Korea
关键词
Upstream Stimulatory Factor; Transforming Growth Factor beta 1; FRTL-5; Cells;
D O I
10.3346/jkms.2008.23.5.870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transforming growth factor-beta 1 (TGF-beta 1) is a potent inhibitor of cellular growth and proliferation by G1 phase arrest or apoptosis. We investigated the association of TGF-beta 1 with the anti-proliferative effect of upstream stimulatory factor (USF) in Fischer rat thyroid cell line (FRTL-5) cells. [Methyl-H-3] thymidine uptake was measured after treatment of FRTL-5 cells with TGF-beta 1 to identify its anti-proliferative effect. USF-1 and USF-2 proteins were in vitro translated, and an electrophoretic mobility shift assay was performed to identify the interaction between USF and the TGF-beta 1 promoter. FRTL-5 cells were transfected with USF cDNA, and then the expression of TGF-beta 1 was examined with Northern and Western blotting. The cell cycle-regulating proteins associated with TGF-beta 1 were also measured. TGF-beta 1 significantly inhibited [methyl-H-3] thymidine uptake in FRTL-5 cells. Two specific binding sites for USF were found in the TGF-beta 1 promoter. -1,846 similar to-1,841 (CACATG) and -621 similar to-616 (CATGTG). Overexpression of USF increased both the mRNA levels and protein levels of TGF-beta 1. However, the expression of cyclin D1, CDK4, cyclin E, and CDK2, and the phosphorylation of retinoblastoma protein remained unchanged. Overexpression of USF in FRTL-5 cells increased the expression of TGF-beta 10 through specific binding to TGF-beta 1 promoter. However, the USF-induced expression of TGF-beta 1 did not cause G1 arrest.
引用
收藏
页码:870 / 876
页数:7
相关论文
共 30 条
  • [1] Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 (TGF-beta 1)
    Asmis, LM
    Kaempf, J
    VonGruenigen, C
    Kimura, ET
    Wagner, HE
    Studer, H
    [J]. JOURNAL OF ENDOCRINOLOGY, 1996, 149 (03) : 485 - 496
  • [2] TGF-β1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth
    Carneiro, C
    Alvarez, CV
    Zalvide, J
    Vidal, A
    Domínguez, F
    [J]. ONCOGENE, 1998, 16 (11) : 1455 - 1465
  • [3] AN RNA POLYMERASE-II TRANSCRIPTION FACTOR BINDS TO AN UPSTREAM ELEMENT IN THE ADENOVIRUS MAJOR LATE PROMOTER
    CARTHEW, RW
    CHODOSH, LA
    SHARP, PA
    [J]. CELL, 1985, 43 (02) : 439 - 448
  • [4] COPPA A, 1995, CELL GROWTH DIFFER, V6, P281
  • [5] TGF-BETA INHIBITION OF CDK4 SYNTHESIS IS LINKED TO CELL-CYCLE ARREST
    EWEN, ME
    SLUSS, HK
    WHITEHOUSE, LL
    LIVINGSTON, DM
    [J]. CELL, 1993, 74 (06) : 1009 - 1020
  • [6] TGFβ1, back to the future -: Revisiting its role as a transforming growth factor
    Glick, AB
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (03) : 276 - 283
  • [7] THE ADENOVIRUS MAJOR LATE TRANSCRIPTION FACTOR USF IS A MEMBER OF THE HELIX LOOP HELIX GROUP OF REGULATORY PROTEINS AND BINDS TO DNA AS A DIMER
    GREGOR, PD
    SAWADOGO, M
    ROEDER, RG
    [J]. GENES & DEVELOPMENT, 1990, 4 (10) : 1730 - 1740
  • [8] Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGFβ1
    Hashimoto, O
    Ueno, T
    Kimura, R
    Ohtsubo, M
    Nakamura, T
    Koga, H
    Torimura, T
    Uchida, S
    Yamashita, K
    Sata, M
    [J]. MOLECULAR CARCINOGENESIS, 2003, 36 (04) : 171 - 182
  • [9] USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells
    Jung, Hye Seung
    Kim, Keun-Sook
    Chung, Yun Jae
    Chung, Hyun-Kyung
    Min, Yong-Ki
    Lee, Myung-Shik
    Lee, Moon-Kyu
    Kim, Kwang-Won
    Chung, Jae Hoon
    [J]. ENDOCRINE JOURNAL, 2007, 54 (02) : 275 - 285
  • [10] Kaklamani Virginia G, 2004, Expert Rev Anticancer Ther, V4, P649, DOI 10.1586/14737140.4.4.649